StockData
BioVie Inc. logo

BioVie Inc. (BIVI) stock

BIVINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as BIVIW
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.00−0.08 (-7.84%)

Close on Nov 17, 2026Market cap $7.51MP/E –Yield –

BioVie enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

BioVie's enterprise value was $526.35K on Nov 11, 2026, against -$13.67M a year earlier. Over the last 5 years it ranged from -$16.42M to $27.85B, with a median of $1.57B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$526.35K–
2025Dec 31, 2025-$16.23M-111.7%
2024Dec 31, 2024$139.11M-97.0%
2023Dec 29, 2023$4.63B-80.2%
2022Dec 30, 2022$23.43B+109.0%
2021Dec 31, 2021$11.21B-53.5%
2020Dec 31, 2020$24.09B+1228.0%
2019Dec 31, 2019$1.81B+750.8%
2018Dec 31, 2018$213.19M-99.9%
2017Dec 29, 2017$238.91B+26.5%
2016Dec 30, 2016$188.79B–

More BioVie figures

See a number that looks wrong?